Medicare and Medicaid Account for Almost $100 Billion of 2013 Prescription Drug Spend
This article was originally published in RPM Report
Executive Summary
Medicare and Medicaid comprised 35.3 percent of the retail prescription drug spending for 2013. Overall prescription drug spending climbed 2.5 percent in 2013, due in part to price increases for brand and specialty drugs, increased spending on new drugs, and increased utilization. This comes as the national health spending hits the lowest spending increase on record.
You may also be interested in...
Drug Shortage Could Be Addressed By ‘Resilience Rating’ From Private Entity Under HHS Plan
US HHS is proposing a public-private partnership to assign ratings to manufacturers based on quality/resilience of supply, tied to a purchasing incentive program for providers. The non-agency approach may be key to overcoming industry and political objections.
Drug Shortage Could Be Addressed By ‘Resilience Rating’ From Private Entity Under HHS Plan
US HHS is proposing a public-private partnership to assign ratings to manufacturers based on quality/resilience of supply, tied to a purchasing incentive program for providers. The non-agency approach may be key to overcoming industry and political objections.
A Final Push For US Hepatitis C Eradication Plan In 2024
The Biden Administration is hoping that it can attach funding for a national hepatitis C ‘subscription’ program into the delayed fiscal 2024 appropriations bills.